The association of interleukin-18 promoter polymorphisms and serum levels with duodenal ulcer, and their correlations with bacterial CagA and VacA virulence factors

Scandinavian Journal of Infectious Diseases

Volumn 45, Issue 8, 2013, Pages 584-592

  Rezaeifar, Alireza ^a   Eskandari Nasab, Ebrahim ^b   Moghadampour, Mehdi ^b   Kharazi Nejad, Eslam ^b   Hasani, Seyed Shahab Adin ^b   Asadi Saghandi, Abolghasem ^c   Hadadi Fishani, Mehdi ^b   Sepanjnia, Adel ^d   Sadeghi Kalani, Behrooz ^d  

^a ZABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CagA and VacA; Helicobacter pylori; Interleukin (IL) 18; Promoter polymorphism

Indexed keywords

CAGA PROTEIN; INTERLEUKIN 18; VACUOLATING TOXIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CAGA PROTEIN, HELICOBACTER PYLORI; VACA PROTEIN, HELICOBACTER PYLORI; VIRULENCE FACTOR;

ADULT; ALLELE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; DUODENUM ULCER; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PHENOTYPE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING; BLOOD; CHEMISTRY; COMPLICATION; DUODENAL ULCER; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; POLYMERASE CHAIN REACTION; SERUM;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; DISEASE SUSCEPTIBILITY; DUODENAL ULCER; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SERUM; VIRULENCE FACTORS;

EID: 84880291616     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2013.794301     Document Type: Article

References (47)

1. Akhiani AA, Schon K, Lycke N. Vaccine-induced immunity against Helicobacter pylori infection is impaired in IL-18-defi cient mice. J Immunol 2004;173:3348-56. (Pubitemid 39142044)
2. Anyona S B, Kempaiah P, Raballah E, Ouma C, Were T, Davenport GC, et al. Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality. Infect Immun 2011;79:4923-32.
3. Bai J, Zhang Y, Lin M, Zeng X, Wang Z, Shen J, et al. Interleukin-18 gene polymorphisms and haplotypes in patients with oral lichen planus: a study in an ethnic Chinese cohort. Tissue Antigens 2007;70:390-7. (Pubitemid 47537401)
4. Bauditz J, Ortner M, Bierbaum M, Niedobitek G, Lochs H, Schreiber S. Production of IL-12 in gastritis relates to infection with Helicobacter pylori. Clin Exp Immunol 1999;117:316-23. (Pubitemid 29343604)
5. Benoit BN, Kobayashi M, Kawakubo M, Takeoka M, Sano K, Zou J, et al. Role of ASC in the mouse model of Helicobacter pylori infection. J Histochem Cytochem 2009;57:327-38.
6. Bossu P, Ciaramella A, Moro M L, Bellincampi L, Bernardini S, Federici G, et al. Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer ' s disease. J Neurol Neurosurg Psychiatry 2007;78:807-11. (Pubitemid 47204582)
7. Caruso R, Pallone F, Monteleone G. Emerging role of IL-23/IL-17 axis in H. pylori-associated pathology. World J Gastroenterol 2007;13:5547-51. (Pubitemid 350031473)
8. Cendron L, Zanotti G. Structural and functional aspects of unique type IV secretory components in the Helicobacter pylori cag-pathogenicity island. FEBS J 2011;278:1223-31.
9. Chen D Y, Hsieh C W, Chen K S, Chen Y M, Lin F J, Lan J L. Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis. Lupus 2009;18:29-37.
10. Day AS, Su B, Ceponis PJ, Jones NL, Yau E, Sieveking D, et al. Helicobacter pylori infection induces interleukin-18 production in gastric epithelial (AGS) cells. Dig Dis Sci 2004;49:1830-5.
11. de Bernard M, D'E lios MM. The immune modulating activity of the Helicobacter pylori HP-NAP: friend or foe? Toxicon 2010, 56, 1186-92
12. D 'E lios MM, Amedei A, Benagiano M, Azzurri A, Del Prete G. Helicobacter pylori, Tcells and cytokines: the " dangerous liaisons ". FEMS Immunol Med Microbiol 2005;44:113-9.
13. D 'Elios M M, Amedei A, Del Prete G. Helicobacter pylori antigen-specifi c T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer and low-grade mucosaassociated lymphoid tissue (MALT) lymphoma. Microbes Infect 2003;5:723-30. (Pubitemid 36695147)
14. D 'Elios M M, Andersen L P. Inflammation, immunity, and vaccines for Helicobacter pylori. Helicobacter 2009;14(Suppl 1):21-8.
15. Dzierzanowska-Fangrat K, Michalkiewicz J, Cielecka-Kuszyk J, Nowak M, Celinska-Cedro D, Rozynek E, et al. Enhanced gastric IL-18 mRNA expression in Helicobacter pyloriinfected children is associated with macrophage infi ltration, IL-8, and IL-1 beta mRNA expression. Eur J Gastroenterol Hepatol 2008;20:314-9. (Pubitemid 351374235)
16. Eskandari-Nasab E, Sepanjnia A, Moghadampour M, Hadadi-Fishani M, Rezaeifar A, Asadi-Saghandi A, et al. Circulating levels of interleukin (IL)-12 and IL-13 in Helicobacter pylori-infected patients, and their associations with bacterial CagA and VacA virulence factors. Scand J Infect Dis 2013;45:342-9.
17. Farinati F, Cardin R, Cassaro M, Bortolami M, Nitti D, Tieppo C, et al. Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. Eur J Cancer Prev 2008;17:195-200. (Pubitemid 351549658)
18. Fera MT, Carbone M, Buda C, Aragona M, Panetta S, Giannone M, et al. Correlation between Helicobacter pylori infection and IL-18 mRNA expression in human gastric biopsy specimens. Ann N Y Acad Sci 2002;963:326-8. (Pubitemid 34721726)
19. Garrote JA, Gomez-Gonzalez E, Bernardo D, Arranz E, Chirdo F. Celiac disease pathogenesis: the proinflammatory cytokine network. J Pediatr Gastroenterol Nutr 2008;47(Suppl 1):S27-32.
20. Giedraitis V, He B, Huang W X, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001;112:146-52.
21. Haghshenas MR, Hosseini SV, Mahmoudi M, Saberi-Firozi M, Farjadian S, Ghaderi A. IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers. J Gastroenterol Hepatol 2009;24:1119-22.
22. Hashemi M, Eskandari-Nasab E, Fazaeli A, Rezaei H, Mashhadi MA, Arbabi F, et al. Bi-directional PCR allelespecifi c amplifi cation (bi-PASA) for detection of caspase-8-652 6N ins/del promoter polymorphism (rs3834129) in breast cancer. Gene 2012;505:176-9.
23. Hong S N, Jo S, Jang J H, Choi J, Kim S, Ahn S Y, et al. Clinical characteristics and the expression profi les of inflammatory cytokines/cytokine regulatory factors in asymptomatic patients with nodular gastritis. Dig Dis Sci 2012;57:1486-95.
24. Jafarzadeh A, Rezayati M T, Nemati M. Specifi c serum immunoglobulin G to H. pylori and CagA in healthy children and adults (south-east of Iran). World J Gastroenterol 2007;13:3117-21. (Pubitemid 47045472)
25. Kawabata T, Ichikura T, Majima T, Seki S, Chochi K, Takayama E, et al. Preoperative serum interleukin-18 level as a postoperative prognostic marker in patients with gastric carcinoma. Cancer 2001;92:2050-5. (Pubitemid 32973313)
26. Kimang' a A, Revathi G, Kariuki S, Sayed S, Devani S, Vivienne M, et al. IL-17A and IL-17F gene expression is strongly induced in the mucosa of H. pylori-infected subjects from Kenya and Germany. Scand J Immunol 2010;72:522-8.
27. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, et al. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 1997;158:1541-50. (Pubitemid 127469506)
28. Lewontin R C. The detection of linkage disequilibrium in molecular sequence data. Genetics 1995;140:377-88.
29. Lin DY, Huang BE. The use of inferred haplotypes in downstream analyses. Am J Hum Genet 2007;80:577-9.
30. Luzza F, Parrello T, Sebkova L, Pensabene L, Imeneo M, Mancuso M, et al. Expression of proinflammatory and Th1 but not Th2 cytokines is enhanced in gastric mucosa of Helicobacter pylori infected children. Dig Liver Dis 2001;33:14-20. (Pubitemid 32186170)
31. Malfertheiner M V, Kandulski A, Schreiber J, Malfertheiner P. Helicobacter pylori infection and the respiratory system: a systematic review of the literature. Digestion 2011;84:212-20.
32. Massarrat S, Saberi-Firoozi M, Soleimani A, Himmelmann GW, Hitzges M, Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol 1995;7:427-33.
33. Ming L, Wen Q, Qiao HL, Dong ZM. Interleukin-18 and IL18-607A/C and-137G/C gene polymorphisms in patients with penicillin allergy. J Int Med Res 2011;39:388-98.
34. Mitchell HM, Hazell SL, Li YY, Hu PJ. Serological response to specifi c Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996;91:1785-8. (Pubitemid 26307183)
35. Molnar B, Galamb O, Sipos F, Leiszter K, Tulassay Z. Molecular pathogenesis of Helicobacter pylori infection: the role of bacterial virulence factors. Dig Dis 2010;28:604-8.
36. Ozen A, Ertem D, Pehlivanoglu E. Natural history and symptomatology of Helicobacter pylori in childhood and factors determining the epidemiology of infection. J Pediatr Gastroenterol Nutr 2006;42:398-404. (Pubitemid 43841022)
37. Queiroz DM, Cunha RP, Saraiva IE, Rocha A M. Helicobacter pylori virulence factors as tools to study human migrations. Toxicon 2010;56:1193-7.
38. Romero-Adrian TB, Leal-Montiel J, Monsalve-Castillo F, Mengual-Moreno E, McGregor EG, Perini L, et al. Helicobacter pylori: bacterial factors and the role of cytokines in the immune response. Curr Microbiol 2010;60:143-55.
39. S akai K, Kita M, Sawai N, Shiomi S, Sumida Y, Kanemasa K, et al. Levels of interleukin-18 are markedly increased in Helicobacter pylori-infected gastric mucosa among patients with specifi c IL18 genotypes. J Infect Dis 2008;197:1752-61. (Pubitemid 351919641)
40. Shimoyama A, Saeki A, Tanimura N, Tsutsui H, Miyake K, Suda Y, et al. Chemical synthesis of Helicobacter pylori lipopolysaccharide partial structures and their selective proinflammatory responses. Chemistry 2011;17:14464-74.
41. Siavoshi F, Malekzadeh R, Daneshmand M, Ashktorab H. Helicobacter pylori endemic and gastric disease. Dig Dis Sci 2005;50:2075-80. (Pubitemid 41504092)
42. Stassi G, Arena A, Speranza A, Iannello D, Mastroeni P. Different modulation by live or killed Helicobacter pylori on cytokine production from peripheral blood mononuclear cells. New Microbiol 2002;25:247-52. (Pubitemid 135746574)
43. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto T, et al. Defective NK cell activity and Th1 response in IL-18-defi cient mice. Immunity 1998;8:383-90. (Pubitemid 28188898)
44. Toka F N, Pack C D, Rouse B T. Molecular adjuvants for mucosal immunity. Immunol Rev 2004;199:100-12. (Pubitemid 38736767)
45. Tomita T, Jackson A M, Hida N, Hayat M, Dixon MF, Shimoyama T, et al. Expression of interleukin-18, aTh1 cytokine, in human gastric mucosa is increased in Helicobacter pylori infection. J Infect Dis 2001;183:620-7. (Pubitemid 32147518)
46. Varbanova M, Malfertheiner P. Bacterial load and degree of gastric mucosal inflammation in Helicobacter pylori infection. Dig Dis 2011;29:592-9.
47. Yamauchi K, Choi I J, Lu H, Ogiwara H, Graham DY, Yamaoka Y. Regulation of IL-18 in Helicobacter pylori infection. J Immunol 2008;180:1207-16.